Hyperprolactinemia is a common clinical disorder due to long-term administration of chemicals such as dopamine D2 receptor antagonists. The role of toxicological evaluation is to protect humans from toxicity induced by drugs or other chemicals and unwanted side effects. It is necessary to assess and differentiate direct toxicological effects of compounds from their secondary effects.
INTRODUCTION
Hyperprolactinemia is a common clinical disorder due to long-term administration of chemicals such as dopamine D2 receptor antagonists. The role of toxicological evaluation is to protect humans from toxicity induced by drugs or other chemicals and unwanted side effects. It is necessary to assess and differentiate direct toxicological effects of compounds from their secondary effects.
The anterior pituitary-grafted rat is well known as a useful model animal for research on hyperprolactinemia; many of which focused on hormonal changes, body weight or glucose metabolism (Matsuda et al., 1994; Reis et al., 1997; Adler, 1986) by means of this model although they had only patchy information. On the other hand, in females, physiological hyperprolactinemia is observed during pregnancy and the subsequent post partum lactation period. Many studies have revealed that prolactin (PRL) is mainly characterized by increases in insulin secretion and islet cell mass in vivo and in vitro and is closely related to glucose (GLU) metabolism in females et al., 1993; Parsons et al., 1995) . However, there is lack of information in males especially regarding the effects of hyperprolactinemia on toxicological parameters.
The present study was designed to clarify the effects of hyperprolactinemia on toxicological parameters using anterior pituitary-grafted male rats. The study took into account sex difference of donors since PRL contents and the proportion of lactotrophs in female rat-derived anterior pituitary grafts are greater than those in their counterparts derived from male rats (McArthur et al., 2006) . Also, the study included the effects of hyperprolactinemia on islet cell proliferation in male rats because sever-al published reports have indicated that anti-dopaminergic chemicals may trigger development of islet cell tumors in male rats but not in females (FDA, 2002 (FDA, , 2006 although the mechanism(s) underlying the tumorigenesis remains induces various changes in toxicological parameters, such as cholinesterase activity (ChE) and elements of lipid metabolism, and there is also the morphology of adrenals and mammary glands along with islet B cell proliferation in male rats.
MATERIALS AND METHODS

Test materials
The materials were obtained as follows: pellet diet CRF-1, Oriental Yeast Co. (Tokyo, Japan); Rat PRL (rPRL) [ 125 I] assay system, Double anti-body RIA method (GE Healthcare Bio-Sciences K.K., Tokyo, Japan), Rat luteinizing hormone (rLH) [ 125 I] assay system, Double anti-body RIA method (GE Healthcare Bio-Sciences K.K.), DPC total testosterone kit, Solidphase RIA method (Diagnostic Products Corporation, Gwynedd, UK) and 5-bromo-2'-deoxy-uridine (BrdU) (Sigma-Aldrich Japan K.K., Tokyo, Japan).
Animals and treatment
All experiments were performed in accordance with The Guide for Animal Care and Use of Sumitomo Chemical Co., Ltd. Male and female F344/DuCrj rats were purchased from Charles River Japan, Inc. (Kanagawa, Japan). They were 3 weeks of age upon arrival and acclimatized to the laboratory environments for 7 days before use. After the acclimatization period, animals judged to be in good health based on their body weights and clinical signs were selected for the study. On the day of operation, randomization method based upon body weights prior to mean body weights among the groups. Some of the male rats were transplanted with three or six anterior pituitaries from male or female littermates under the kidney capsules and others sham-operated (Table 1 ). The number of grafted pituitaries was chosen based on a previous study (unpublished data). PRL concentration in male F344 rats transplanted two anterior pituitaries from male littermates under the kidney capsules was only 1.3 times higher than that in the sham group at 8 weeks after operation. Therefore, 3 or 6 pituitary glands were set in this study. Furthermore, both of a male and a female littermate donor group in the 3-pituitary-grafted groups were set in order to examine the effects of sex difference in the donors on PRL levels. Animals were 4 weeks of age at the operation, and the observation was performed for the following 13 weeks.
Rats were housed two per cage in stainless steel wire bottom cages under the following controlled environmental conditions; a temperature of 24 ± 2°C, a relative humidity of 55 ± 10 %, a frequency of ventilation with more than 10 exchanges/hr, and a 12-hr light/dark cycle (light on, 08:00-20:00). Drinking water and pellet rodent diet were available ad libitum.
Clinical observation and body weights
The animals were individually observed daily for mortality and weekly for clinical signs throughout the study period. Body weights and food consumption were measured weekly.
Hematology and blood biochemistry
The animals were anesthetized with ether and blood samples were collected from the abdominal aorta at the end of the study (week 13). A portion of blood sample was anti-coagulated by EDTA-2K and then examined for the following hematological parameters with a Hematology Analyzer H1 (Bayer Corporation, New York, NY, USA); erythrocyte counts (RBC), hemoglobin concentration (HGB), hematocrit value (HCT), mean corpuscular hemoglobin (MCH), mean corpuscular volume (MCV), Mean corpuscular hemoglobin concentration (MCHC), platelet counts (PLT), leukocyte counts (WBC) and differential leukocyte count (basophil (Baso), eosinophil (Eos), lymphocyte (Lymp), monocyte (Mono), neutrophil (Neut)). Reticulocyte count (RET) was assessed with an Automated Reticulocyte Analyzer R-1000 (Toa Medical Electronics Co., Ltd., Hyogo, Japan). Additionally, another portion of blood sample was anti-coagulated with sodium citrate and then the following parameters were measured with an Automated Blood Coagulation Analyzer CA-5000 (Toa Medical Electronics Co., Ltd.); prothrombin time (PT), activated partial thromboplastin time Plasma was obtained from anti-coagulated blood with heparin sodium and the following biochemical parameters were measured with a Biochemistry Analyzer CHEM 1 (Bayer Corporation); total protein (TP), albumin (ALB), A/G ratio (A/G), glucose (GLU), total cholesterol (T.Cho), triglyceride (TG), phospholipids (PL), aspartic animotransferase (AST), alanine animotransferase (ALT), alkaline phsphatase (ALP), g-glutamyl transpeptidase (g-GTP), lactase dehydrogenase (LDH), creatine phosphokinase (CPK), leucine animopeptidase (LAP), cholinesterase activity (ChE), total bilirubin (T.Bil), direct bilirubin (D.Bil), blood urea nitrogen (BUN), creatinine (Cre), inorganic phosphorus (IP), sodium (Na), potassium (K), chloride (Cl) and calcium (Ca).
Hormone measurement
At week 8, blood was sampled from the jugular vein under ether anesthesia and serum was obtained to assay PRL. At week 13, serum was prepared from the remaining blood and the following hormones were assayed; PRL, leutenizing hormone (LH), growth hormone (GH) and insulin. The serum was stored at -80°C until measurement. PRL was assayed with rPRL [ 125 I] assay system (Amersham International plc, Buckinghamshire, UK), and LH, GH and insulin were determined at SRL (Osaka, Japan).
Organ weights
organs and tissues were removed from all animals and weighed: as spleen, liver, lung, adrenals * , heart, brain, thymus, testes, thyroids (with parathyroid gland) * , pituitary * and ventral prostate * . Star-marked tissues were -ered formalin.
Pathological examination
All the organs and tissues dissected were subjected to necropsy along with carcasses. The pancreas, adrenal, mammary gland, pituitary and subcapsular pituitary -toxylin and eosin (H.E), and then examined microscopically.
Islet cells proliferation
One week before necropsy, osmotic mini pump was implanted subcutaneously in the dorsal area of each animal under ether anesthesia. The animals were continuous--tionizing a pancreas tissue, immunohistochemical staining was carried out in the tissue for co-localization of insulin and BrdU. Firstly, localized nuclear-incorporated BrdU was demonstrated by ABC method and peroxidase activity was detected using diaminobenzidine. Secondary, the pancreatic section immunostained for BrdU (monoclonal mouse anti-bromodeoxyuridine, Clone Bu20a, Dako, -body for insulin: A564 (guinea pig anti-porcine insulin, Dako), overnight at 4°C (1:200 diluted with phosphatebuffered saline) as specified in the streptavidin biotin used for nuclear staining and alkali phosphatase activity, respectively.
For BrdU labeling index of B cells, more than 1,000 of randomly chosen islet cells were counted then the percentages of labeled cells per total cells counted were calculated.
Statistical analysis
The data for body weights, body weight gains, hematology, blood biochemistry, hormone measurement, organ weights, ratio of organ weight to body weight and BrdU labeling index were subjected to Student's t-test to deterand standard deviation of each group were calculated. The levels of P < 0.01 and P < 0.05 were considered to be
RESULTS
Serum PRL level
Increased PRL levels were observed in the Graft I, II and Graft III groups at both weeks 8 and 13 (Fig. 1) . The values were 21.0, 64.7, 54.0 and 106.0 ng/ml at week 8, and 36.0, 70.0, 75.0 and 105.4 ng/ml at week 13 in the sham, Graft I, Graft II and Graft III groups, respectively. All Graft groups compared to the sham group, and hyperprolactinemia was clearly already induced at week 8.
Clinical signs, body weights and food consumption
No clinical signs attributable to hyperprolactinemia were found throughout the study period (data not shown). In the Graft I group, one animal died at 89 days after operation. Although the reasons for the death were unclear, this was not observed in the Graft III group and was considered unrelated to the high PRL level. Body weights (Table 2 and Fig. 2 ) and food consumption (Table 2 ) of all pituitary grafted groups were almost identical to those of the sham group during the study.
Hematology and blood biochemistry
In hematology, significantly lower RBC and fibrinogens, and higher MCV and MCH were observed in all Graft groups, in addition to increased MCHC, in the Graft III group (Table 3) . Although lymphocyte counts and RET were decreased in the Graft I and Graft II groups, respectively; this was not considered to be due to the higher levels of PRL since there was no comparable depression in the Graft II and III groups and there was no correlation with serum PRL concentrations.
In blood biochemistry, significantly lower triglycerides, and higher T.Cho and ChE were observed in all ratio, GLU and Na, and elevation of PL and IP were also -els of T.Bil and K were further noted in the Graft I and/ or Graft II groups. However, this was not observed in the Graft III group and was considered unrelated to the high PRL level.
Hormone analysis
in all Graft groups (Table 5 ). Insulin levels in the Graft I and II groups were comparable to that in the Sham group; however, insulin levels in the Graft III group tended to be were observed in the sham group due to the two abnormal values, and the level in the remaining rats was in the range of 2.7 to 4.8 ng/ml. It is therefore considered that there was no change in GH related to hyperprolactinemia.
Organ weights
The absolute and relative weights of adrenal glands (2) 15 (2) Each value represents the mean ± S.D. except for food consumption (mean only). Parenthetic number represents the number of animals (cages in food consumption) measured. In the Graft I group, one animal died at 89 days after operation. Rats were housed two per cage. Food consumption for each cage was measured and the daily consumption per animal was calculated.
( Table 6 ). The weights of the adrenal glands in the Graft II group tend to be increased although this was not statistically significant. The remaining organs showed no changes attributable to hyperprolactinemia.
Gross pathology and Histopathology
No hyperprolactinemia-related effects were found in gross pathology (data not shown). Histopathological assessment revealed hypertrophy of zona reticularis in the adrenal glands in all animals of the Grafted groups (Table 7 and Fig. 3 ). In the mammary glands, a tubularalveolar pattern was observed in the Graft groups, instead of the lobular-alveolar pattern, which was originally observed in male rats (Table 7 and Fig. 4 ). Both pituitaries and grafted pituitaries had no obvious abnormalities.
Islet cell proliferation
The BrdU labeling indices for Langerhans B cells were 2.19, 2.56, 2.95 and 3.66 % in the Sham, Graft I, Graft II and Graft III groups, respectively. The Graft II and Graft -between the serum PRL concentration and the BrdU labeling index was 0.69, this being statistically significant (Fig. 5) . (mEq/l) 137 ± 0.8 137 ± 0.5 138 ± 0.9 136 ± 0.5* K (mEq/l) 3.6 ± 0.37 3.3 ± 0.16 3.1 ± 0.12* 3.4 ± 0.37 Cl (mEq/l) 98 ± 2.0 98 ± 1.5 99 ± 1.9 100 ± 1.0 Ca (mg/dl) 10.2 ± 0.12 10.1 ± 0.10 10.1 ± 0.07 10.2 ± 0.08 IP (mg/dl) 3.7 ± 0.44 3.9 ± 0.59 3.9 ± 0.49 4.6 ± 0.31** Each value represents the mean ± S.D. of 4 to 6 rats. Table 5 . Effects of hyperprolactinemia on serum levels of LH, GH, and insulin LH GH Insulin Group (ng/ml) (ng/ml) (ng/ml) Sham 1.35 ± 0.055 (6) 21.5 ± 27.97 (6) 9.9 ± 3.63 (6) Graft I 1.10 ± 0.141** (4) 6.2 ± 1.91 (4) 9.8 ± 3.67 (4) Graft II 1.20 ± 0.071** (5) 4.1 ± 0.55 (5) 10.5 ± 6.32 (5) Graft III 1.10 ± 0.082** (4) 9.0 ± 6.69 (4) 6.9 ± 2.93 (4) Each value represents the mean ± S.D.. Parenthetic number represents the number of animals measured. 
DISCUSSION
In the present study, the grafted pituitaries, fixed to the renal capsule, reliably induced hyperprolactinemia. On the basis of the published report that PRL content and portion of lactotrophs in the female rat-derived anterior pituitary are greater than their male-derived counterparts (McArthur et al., 2006) , it was expected that the PRL level would be higher in female-derived pituitary-grafted rats. However, there were no differences in serum PRL levels dependent on the sex of the donor in this study (Fig. 1) . PRL cells in the anterior pituitary were more abundant in female rats during estrus than in males, but no differences could be detected after gonadectomy, and estrogen is a key factor of cell proliferation of the pituitary grand (Oishi et al., 1993) . The estrogen begins to be synthesized in the ovary immediately after weaning, and then blood levels of estrogen are gradually increased. Since the donor rats were only 4 weeks of age at operation, the -ate the cell proliferation of the pituitary gland. Therefore, it is considered that serum PRL levels are not subject to the sex of the donor since PRL content in the male-and female-derived grafted pituitary is consistent between both sexes at the time of operation. The serum PRL level in 6-pituitary-grafted rats was 1.5-to 2-fold higher than that in 3-pituitary-grafted rats, this positive relationship between the number of implanted pituitary glands and serum PRL concentration being in line with expectation and a previous report (Adler, 1986) . Regarding the duration of implantation, given that the serum PRL concentrations at 8 week after operation were as high as those at 13 that hyperprolactinemia was already induced at 8 weeks after operation.
The outcomes consistent with other reports include the lack of clinical signs related to hyperprolactinemia during the study, and the absence of effects on body weights and food consumption (Adler, 1986) (Table 2 ). In blood biochemistry, blood GLU was slightly lowered in the Graft III group (Table 4) . Insulin facilitates GLU uptake into organs/tissues and changes GLU metabolism in the body. Although insulin release is a PRL-stimulated activity the observed insulin levels did not increase in this study and in the Graft III group (Table 5) . PRL has been called a diabetogenic hormone (Landgraf et al., 1977) and longterm hyperglycemia has been reported to be induced in pituitary-grafted rats and mice (Matsuda et al., 1996; Reis et al., 1997) . GLU turnover is stabilized within a range of slight deviations in the balance between anabolism and catabolism, so that either hyperglycemia or hypoglycemia could be induced in hyperprolactinemic animals. Excessive body weight gain, obesity and increased GLU levels -sychotic drug treatments (Baptista et al., 2002) . However, there were no coincident results in the present study of hyperprolactinemia.
All Graft groups here exhibited elevated ChE and T.Cho in addition to the lowering of triglycerides and leutenizing hormones (Table 4) . Moreover high phospholipid levels were apparent in the Graft III group (Table 4) . Elevated ChE activity and lowered TG were frequently reported in hyperprolactinemic rats induced by antidopaminergic drugs (Cauteren et al., 1993; Nomura et al., 1985) . However, the changes of T.Cho and PL were inconsistent with the results in other studies (Yamatsugi et al., 1985; Matsuzawa et al., 1989) . On the other hand, ChE and serum levels of T.Cho and TG are influenced by gonadectomy and restored by sex hormone replacement (Illsley and Lamartiniere, 1981; Liu et al., 2004; Frauscher and Lubec, 1994) . Considering that a decrease of testosterone was expected to parallel the outcome of a decreased LH (Table 5) , the changes observed in this study were somehow mediated by variations of hormonal environment induced by hyperprolactinemia. The appearance of tubuloalveolar structures in the mammary glands deserves comment, however. Treatment with a dopamine antagonist in male rats for 52 weeks similarly caused transformation to the female tubuloalveolar morphology (Lucus et al., 2007) . Hormones such as androgens and GH are capable of promoting duct development independently, and hyperprolactinemia itself can produce mammary gland feminization (Lucus et al., 2007) . Since GH was unchanged (Table 5 ) and a decrease of testosterone was expected to be the outcome as mentioned above, the changes in the mammary glands were likely due to hyperprolactinemia itself or a decreased testosterone induced by hyperprolactinemia. The weights of absolute and relative adrenal glands of grafted animals were generally increased, consistent with an earlier report . Sex differences exist in adrenal gland weights, with larger values in females. Therefore, In histopathology, hypertrophy of zona reticularis of the adrenal glands was observed in all pituitary-grafted animals (Table 7) . Hyperprolactinemia induced by pituitary graft increases the release of corticosterone from zona reticularis cells (Chang et al., 1999) . Also adreno cortico tropic hormone (ACTH), which is the major hormone regulating glucocorticoid secretion, usually affects the zona fasciculate of the adrenal glands, and PRL increases ACTH and corticosterone release not only from the zona fasciculate but also from zona reticularis cells in vitro (Chang et al., 1999) . Increased ACTH in pituitary grafted rats may stimulate zona reticularis cells in the adrenal glands and thus cause increase in their weights. Based on the above-mentioned results, it is suggested that PRL is somehow associated with hormonal circumstances, especially sex difference.
In hematology, slightly lower RBC was observed in all Graft groups compared to the sham group. Elevated PRL levels are acknowledged in pregnant women with nutritional anemia and in anemic dialysis patients (Ramirez et al., 1992; Mahajan et al., 2008) . Decreased RBC, HCT and HGB are reported in rats treated with some anti-dopaminergic agents, such as bromperidol, tiapride hydrochloride and emonapride (Horizoe et al., 1984; 
a) b)
et Matsuzawa et al., 1989) . Therefore, there may be some sort of relationship between PRL and erythrocyte proliferation although it is unknown whether or not PRL directly affects erythrocyte proliferation. However, the relationship is likely to be exaggerated on the condition that HGB, HCT and RET were unchanged. For elevated MCV, MCH and MCHC, they were considered to be a compensatory reaction (Table 3) . Further studies are needed to reveal the relationship between lowered RBC -ered in all grafted groups. Neither clear change in other parameters related to blood coagulation abilities nor any dose-relation to serum PRL concentrations was observed. Therefore, it is reasonable to assume that they were not hyperprolactinemia-related effects. In blood biochemistry, lower A/G ratio and Na were observed in the Graft III group (Table 4) . However, this was considered incidental because other related parameters were unchanged or demonstrated only very slight change alteration with no doserelationship to the serum PRL concentration.
The BrdU labeling index of pancreatic islet cells was it tended to be higher in the Graft I group (Fig. 5) . Furthermore, the BrdU labeling index statistically correlated with serum PRL concentration at week 13 (correlation factor r = 0.69, p < 0.05). These results suggest that PRL is involved into pancreatic cell proliferation in male rats. Insulin and GH are potent growth factors for the differentiated pancreatic B cells (Brelje et al., 1993 (Brelje et al., , 1994 , but neither was increased in this study (Table 5) . Therefore, they presumably were not involved in proliferation of islet cells under our experimental conditions. Glucocorticoids are known to alter pancreatic weight and function (Matsuda et al., 1994) . However, dexamethasone (DEX) increased the amount of islet cell death (apoptosis) and counteracted the effect of PRL on islet function in an in vitro study (Weinhaus et al., 2000) . PRL induces islet B-cell proliferation; especially during pregnancy (Brelje and Sorenson, 1991) , and insulin secretion and Brat islets cultured with PRL (Brelje et al., 1994) . Based on the above results, it is indicated that islet B-cell proliferation is induced by PRL itself in male rats. The purpose of the present study was to explore the effects of hyperprolactinemia on islet cell proliferation in the pancreas and on toxicological parameters. This is the on almost all toxicological parameters at one time. When anterior pituitaries were grafted under the kidney capsule -pared to control level. Hyperprolactinemia enhanced islet cell proliferation and there was a statistically positive correlation between serum PRL levels and BrdU labeling indices. Regarding toxicological parameters, T.Cho, ChE and PL were increased while triglyceride, GLU and luteinized hormone were decreased in addition to increased Vol. 34 No. 2 adrenal gland weights. In histopathology, hypertrophy of zona reticularis of adrenal glands and tubular-alveolar structure in the mammary gland were observed in all grafted groups. In conclusion, all evidence points to the fact that hyperprolactinemia results in some changes in toxicological parameters, including ChE, lipid metabolic parameters and histopathological evaluations of adrenals and mammary glands. More importantly, PRL appears to in male rats.
